China · 
Who invested in GT Apeiron Therapeutics?
GT Apeiron Therapeutics's investors include GT Healthcare Capital Partners.
China · Funded startup
Who invested in GT Apeiron Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow GT Apeiron Therapeutics and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$27Mraised across 1 round since 2019, from 1 source
- Latest round
- Round, $27MJun 2019
- Investors
- 1
The rounds
- Jun 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about GT Apeiron Therapeutics
How much has GT Apeiron Therapeutics raised?
GT Apeiron Therapeutics has raised $27M across 1 round since 2019.
When did GT Apeiron Therapeutics last raise?
GT Apeiron Therapeutics's most recent round was an Undisclosed round of $27M in Jun 2019.
What was GT Apeiron Therapeutics's biggest round?
Its most recent round, $27M in Jun 2019, is also its largest on record.
Who backed GT Apeiron Therapeutics first?
GT Apeiron Therapeutics's first round on record, in Jun 2019, was backed by GT Healthcare Capital Partners.
What stage is GT Apeiron Therapeutics at?
GT Apeiron Therapeutics's latest named round is an Undisclosed round, in Jun 2019.
Where is GT Apeiron Therapeutics based?
GT Apeiron Therapeutics is based in China.
Companies like GT Apeiron Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.